Matches in SemOpenAlex for { <https://semopenalex.org/work/W4282555670> ?p ?o ?g. }
- W4282555670 abstract "Non-motor symptoms (NMS) are common among patients with Parkinson's disease and reduce patients' quality of life (QOL). However, there remain considerable unmet needs for NMS management. Three monoamine oxidase B inhibitors (MAO-BIs), selegiline, rasagiline, and safinamide, have become commercially available in many countries. Although an increasing number of studies have reported potential beneficial effects of MAO-BIs on QOL and NMS, there has been no consensus. Thus, the primary objective of this study was to provide an up-to-date systematic review of the QOL and NMS outcomes from the available clinical studies of MAO-BIs. We conducted a literature search using the PubMed, Scopus, and Cochrane Library databases in November 2021. We identified 60 publications relevant to this topic. Overall, rasagiline and safinamide had more published evidence on QOL and NMS changes compared with selegiline. This was likely impacted by selegiline being introduced many years prior to the field embarking on the study of NMS. The impact of MAO-BIs on QOL was inconsistent across studies, and this was unlikely to be clinically meaningful. MAO-BIs may potentially improve depression, sleep disturbances, and pain. In contrast, cognitive and olfactory dysfunctions are likely unresponsive to MAO-BIs. Given the paucity of evidence and controlled, long-term studies, the effects of MAO-BIs on fatigue, autonomic dysfunctions, apathy, and ICD remain unclear. The effects of MAO-BIs on static and fluctuating NMS have never been investigated systematically. More high-quality studies will be needed and should enable clinicians to provide personalized medicine based on a non-motor symptom profile." @default.
- W4282555670 created "2022-06-14" @default.
- W4282555670 creator A5002282550 @default.
- W4282555670 creator A5007715932 @default.
- W4282555670 creator A5009131134 @default.
- W4282555670 creator A5020932704 @default.
- W4282555670 creator A5026898221 @default.
- W4282555670 creator A5030798280 @default.
- W4282555670 creator A5036681718 @default.
- W4282555670 creator A5048537838 @default.
- W4282555670 creator A5056665061 @default.
- W4282555670 creator A5060194088 @default.
- W4282555670 date "2022-06-13" @default.
- W4282555670 modified "2023-10-18" @default.
- W4282555670 title "Effects of MAO-B inhibitors on non-motor symptoms and quality of life in Parkinson’s disease: A systematic review" @default.
- W4282555670 cites W1510881087 @default.
- W4282555670 cites W1547633323 @default.
- W4282555670 cites W1631523450 @default.
- W4282555670 cites W1728922767 @default.
- W4282555670 cites W1895780774 @default.
- W4282555670 cites W1955427182 @default.
- W4282555670 cites W1975546859 @default.
- W4282555670 cites W1978135077 @default.
- W4282555670 cites W1988848669 @default.
- W4282555670 cites W1990967797 @default.
- W4282555670 cites W1993831043 @default.
- W4282555670 cites W2000450717 @default.
- W4282555670 cites W2018021370 @default.
- W4282555670 cites W2018070489 @default.
- W4282555670 cites W2020658097 @default.
- W4282555670 cites W2021374461 @default.
- W4282555670 cites W2021828427 @default.
- W4282555670 cites W2039676559 @default.
- W4282555670 cites W2040625291 @default.
- W4282555670 cites W2043285298 @default.
- W4282555670 cites W2046480055 @default.
- W4282555670 cites W2062309915 @default.
- W4282555670 cites W2063956606 @default.
- W4282555670 cites W2064978296 @default.
- W4282555670 cites W2065268878 @default.
- W4282555670 cites W2068069924 @default.
- W4282555670 cites W2070500117 @default.
- W4282555670 cites W2074895627 @default.
- W4282555670 cites W2076150166 @default.
- W4282555670 cites W2101619031 @default.
- W4282555670 cites W2101683457 @default.
- W4282555670 cites W2109168040 @default.
- W4282555670 cites W2111446787 @default.
- W4282555670 cites W2120824167 @default.
- W4282555670 cites W2120837834 @default.
- W4282555670 cites W2124065800 @default.
- W4282555670 cites W2124680543 @default.
- W4282555670 cites W2144323820 @default.
- W4282555670 cites W2147111512 @default.
- W4282555670 cites W2147554125 @default.
- W4282555670 cites W2152837663 @default.
- W4282555670 cites W2158665663 @default.
- W4282555670 cites W2172952996 @default.
- W4282555670 cites W2214196459 @default.
- W4282555670 cites W2272517425 @default.
- W4282555670 cites W2274773826 @default.
- W4282555670 cites W2312985092 @default.
- W4282555670 cites W2340187965 @default.
- W4282555670 cites W2411905904 @default.
- W4282555670 cites W2462950632 @default.
- W4282555670 cites W2504570392 @default.
- W4282555670 cites W2516725864 @default.
- W4282555670 cites W2521232714 @default.
- W4282555670 cites W2526523672 @default.
- W4282555670 cites W2530613825 @default.
- W4282555670 cites W2563082987 @default.
- W4282555670 cites W2565395340 @default.
- W4282555670 cites W2586368171 @default.
- W4282555670 cites W2586981706 @default.
- W4282555670 cites W2595176684 @default.
- W4282555670 cites W2743373424 @default.
- W4282555670 cites W2745165369 @default.
- W4282555670 cites W2758054925 @default.
- W4282555670 cites W2769410386 @default.
- W4282555670 cites W2770294408 @default.
- W4282555670 cites W2781587184 @default.
- W4282555670 cites W2783823953 @default.
- W4282555670 cites W2792469321 @default.
- W4282555670 cites W2794483059 @default.
- W4282555670 cites W2802484839 @default.
- W4282555670 cites W2805497424 @default.
- W4282555670 cites W2810687814 @default.
- W4282555670 cites W2811061566 @default.
- W4282555670 cites W2886692584 @default.
- W4282555670 cites W2888888324 @default.
- W4282555670 cites W2889379121 @default.
- W4282555670 cites W2898886529 @default.
- W4282555670 cites W2902694393 @default.
- W4282555670 cites W2908548900 @default.
- W4282555670 cites W2909614014 @default.
- W4282555670 cites W2913082859 @default.
- W4282555670 cites W2975835807 @default.
- W4282555670 cites W2976680412 @default.
- W4282555670 cites W3009580564 @default.
- W4282555670 cites W3023737799 @default.